Nox2 Inhibition as Anti-nitration Strategy
1
1. Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., and Freeman,
conjugated cyclic methylenephosphorane. J. Chem. Soc. C, 2003–2005
B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: im- 31. Goy, R., Apfel, U. P., Elleouet, C., Escudero, D., Elstner, M., G o¨ rls, H.,
plications for endothelial injury from nitric oxide and superoxide. Proc.
Natl. Acad. Sci. U.S.A. 87, 1620–1624
Talarmin, J., Schollhammer, P., Gonz a´ lez, L., and Weigand, W. (2013) A
silicon-heteroaromatic system as photosensitizer for light-driven hydro-
gen production by hydrogenase mimics. Eur. J. Inorg. Chem. 2013,
4466–4472
1
1
1
2. Radi, R., Beckman, J. S., Bush, K. M., and Freeman, B. A. (1991) Peroxyni-
trite oxidation of sulfhydryls. The cytotoxic potential of superoxide and
nitric oxide. J. Biol. Chem. 266, 4244–4250
32. Sikora, A., Zielonka, J., Lopez, M., Dybala-Defratyka, A., Joseph, J., Mar-
cinek, A., and Kalyanaraman, B. (2011) Reaction between peroxynitrite
and boronates: EPR spin-trapping, HPLC analyses, and quantum mechan-
ical study of the free radical pathway. Chem. Res. Toxicol. 24, 687–697
33. Zielonka, J., Sikora, A., Joseph, J., and Kalyanaraman, B. (2010) Peroxyni-
trite is the major species formed from different flux ratios of co-generated
nitric oxide and superoxide: direct reaction with boronate-based fluores-
cent probe. J. Biol. Chem. 285, 14210–14216
3. Beckman, J. S. (2009) Understanding peroxynitrite biochemistry and its
potential for treating human diseases. Arch. Biochem. Biophys. 484,
1
14–116
4. Al Ghouleh, I., Khoo, N. K., Knaus, U. G., Griendling, K. K., Touyz, R. M.,
Thannickal, V. J., Barchowsky, A., Nauseef, W. M., Kelley, E. E., Bauer,
P. M., Darley-Usmar, V., Shiva, S., Cifuentes-Pagano, E., Freeman, B. A.,
Gladwin, M. T., and Pagano, P. J. (2011) Oxidases and peroxidases in
cardiovascular and lung disease: new concepts in reactive oxygen species 34. Van de Bittner, G. C., Dubikovskaya, E. A., Bertozzi, C. R., and Chang, C. J.
signaling. Free Radic. Biol. Med. 51, 1271–1288
(2010) In vivo imaging of hydrogen peroxide production in a murine tu-
mor model with a chemoselective bioluminescent reporter. Proc. Natl.
Acad. Sci. U.S.A. 107, 21316–21321
1
1
5. Pacher, P., Beckman, J. S., and Liaudet, L. (2007) Nitric oxide and per-
oxynitrite in health and disease. Physiol. Rev. 87, 315–424
6. Ye, Y., Quijano, C., Robinson, K. M., Ricart, K. C., Strayer, A. L., Sahawneh,
M. A., Shacka, J. J., Kirk, M., Barnes, S., Accavitti-Loper, M. A., Radi, R.,
35. Cohen, H. J., Chovaniec, M. E., and Ellis, S. E. (1980) Chlorpromazine
inhibition of granulocyte superoxide production. Blood 56, 23–29
Beckman, J. S., and Est e´ vez, A. G. (2007) Prevention of peroxynitrite- 36. Seredenina, T., Chiriano, G., Filippova, A., Nayernia, Z., Mahiout, Z., Fio-
induced apoptosis of motor neurons and PC12 cells by tyrosine-contain-
ing peptides. J. Biol. Chem. 282, 6324–6337
raso-Cartier, L., Plastre, O., Scapozza, L., Krause, K. H., and Jaquet, V.
(2015) A subset of N-substituted phenothiazines inhibits NADPH oxi-
dases. Free Radic. Biol. Med. 86, 239–249
1
1
7. Guzik, T. J., and Harrison, D. G. (2006) Vascular NADPH oxidases as drug
targets for novel antioxidant strategies. Drug Discov. Today 11, 524–533
8. Cifuentes-Pagano, E., Meijles, D. N., and Pagano, P. J. (2014) The quest for
selective nox inhibitors and therapeutics: challenges, triumphs and pit-
falls. Antioxid. Redox Signal. 20, 2741–2754
37. Burkhart, R. A., Peng, Y., Norris, Z. A., Tholey, R. M., Talbott, V. A., Liang,
Q., Ai, Y., Miller, K., Lal, S., Cozzitorto, J. A., Witkiewicz, A. K., Yeo, C. J.,
Gehrmann, M., Napper, A., Winter, J. M., et al. (2013) Mitoxantrone
targets human ubiquitin-specific peptidase 11 (USP11) and is a potent
inhibitor of pancreatic cancer cell survival. Mol. Cancer Res. 11, 901–911
1
2
9. Michalski, R., Zielonka, J., Hardy, M., Joseph, J., and Kalyanaraman, B.
(
2013) Hydropropidine: a novel, cell-impermeant fluorogenic probe for 38. Baell, J. B., and Holloway, G. A. (2010) New substructure filters for re-
detecting extracellular superoxide. Free Radic. Biol. Med. 54, 135–147
moval of pan assay interference compounds (PAINS) from screening li-
braries and for their exclusion in bioassays. J. Med. Chem. 53, 2719–2740
0. Zielonka, J., Sikora, A., Hardy, M., Joseph, J., Dranka, B. P., and Kaly-
anaraman, B. (2012) Boronate probes as diagnostic tools for real time 39. Baell, J., and Walters, M. A. (2014) Chemistry: chemical con artists foil
monitoring of peroxynitrite and hydroperoxides. Chem. Res. Toxicol.
5, 1793–1799
drug discovery. Nature 513, 481–483
2
40. Sikora, A., Zielonka, J., Lopez, M., Joseph, J., and Kalyanaraman, B. (2009)
Direct oxidation of boronates by peroxynitrite: mechanism and implica-
tions in fluorescence imaging of peroxynitrite. Free Radic. Biol. Med. 47,
1401–1407
2
1. Zielonka, J., Sikora, A., Adamus, J., and Kalyanaraman, B. (2015) Detection
and differentiation between peroxynitrite and hydroperoxides using mi-
tochondria-targeted arylboronic acid. Methods Mol. Biol. 1264, 171–181
2. Sikora, A., Zielonka, J., Adamus, J., Debski, D., Dybala-Defratyka, A., Mi-
chalowski, B., Joseph, J., Hartley, R. C., Murphy, M. P., and Kalyanaraman,
B. (2013) Reaction between peroxynitrite and triphenylphosphonium-
substituted arylboronic acid isomers: identification of diagnostic marker
products and biological implications. Chem. Res. Toxicol. 26, 856–867
3. Zhao, H., Joseph, J., Fales, H. M., Sokoloski, E. A., Levine, R. L., Vasquez-
2
41. Ximenes, V. F., Morgon, N. H., and de Souza, A. R. (2015) Hypobromous
acid, a powerful endogenous electrophile: experimental and theoretical
studies. J. Inorg. Biochem. 146, 61–68
42. Kumar, K., and Margerum, D. W. (1987) Kinetics and mechanism of gen-
eral-acid-assisted oxidation of bromide by hypochlorite and hypochlorous
acid. Inorg. Chem. 26, 2706–2711
2
Vivar, J., and Kalyanaraman, B. (2005) Detection and characterization of 43. Drummond, G. R., Selemidis, S., Griendling, K. K., and Sobey, C. G. (2011)
the product of hydroethidine and intracellular superoxide by HPLC and
Combating oxidative stress in vascular disease: NADPH oxidases as ther-
apeutic targets. Nat. Rev. Drug Discov. 10, 453–471
limitations of fluorescence. Proc. Natl. Acad. Sci. U.S.A. 102, 5727–5732
2
2
4. Zielonka, J., Vasquez-Vivar, J., and Kalyanaraman, B. (2008) Detection of 44. Jaquet, V., Scapozza, L., Clark, R. A., Krause, K. H., and Lambeth, J. D.
2
-hydroxyethidium in cellular systems: a unique marker product of super-
(2009) Small-molecule NOX inhibitors: ROS-generating NADPH oxi-
dases as therapeutic targets. Antioxid. Redox Signal. 11, 2535–2552
oxide and hydroethidine. Nat. Protoc. 3, 8–21
5. Teufelhofer, O., Weiss, R. M., Parzefall, W., Schulte-Hermann, R., Mick- 45. Mukhopadhyay, P., Horv a´ th, B., Zsengell e´ r, Z., Zielonka, J., Tanchian, G.,
sche, M., Berger, W., and Elbling, L. (2003) Promyelocytic HL60 cells
express NADPH oxidase and are excellent targets in a rapid spectropho-
tometric microplate assay for extracellular superoxide. Toxicol. Sci. 76,
Holovac, E., Kechrid, M., Patel, V., Stillman, I. E., Parikh, S. M., Joseph, J.,
Kalyanaraman, B., and Pacher, P. (2012) Mitochondrial-targeted antioxi-
dants represent a promising approach for prevention of cisplatin-induced
nephropathy. Free Radic. Biol. Med. 52, 497–506
3
76–383
2
6. Seitz, P. M., Cooper, R., Gatto, G. J., Jr., Ramon, F., Sweitzer, T. D., Johns, 46. Deng, Y., Thompson, B. M., Gao, X., and Hall, E. D. (2007) Temporal
D. G., Davenport, E. A., Ames, R. S., and Kallal, L. A. (2010) Development
of a high throughput cell-based assay for superoxide production in HL-60
cells. J. Biomol. Screen. 15, 388–397
relationship of peroxynitrite-induced oxidative damage, calpain-medi-
ated cytoskeletal degradation and neurodegeneration after traumatic
brain injury. Exp. Neurol. 205, 154–165
2
7. Zhang, J. H., Chung, T. D., and Oldenburg, K. R. (1999) A simple statistical 47. Khan, M., Dhammu, T. S., Matsuda, F., Annamalai, B., Dhindsa, T. S.,
parameter for use in evaluation and validation of high throughput screen-
ing assays. J. Biomol. Screen. 4, 67–73
Singh, I., and Singh, A. K. (2016) Targeting the nNOS/peroxynitrite/cal-
pain system to confer neuroprotection and aid functional recovery in a
mouse model of TBI. Brain Res. 1630, 159–170
2
8. Nicholls, D. G., Darley-Usmar, V. M., Wu, M., Jensen, P. B., Rogers, G. W.,
and Ferrick, D. A. (2010) Bioenergetic profile experiment using C2C12 48. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., So-
myoblast cells. J. Vis. Exp. 46, 2511
tomayor, E., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., and Gabrilov-
ich, D. I. (2009) Mechanism regulating reactive oxygen species in tumor-
induced myeloid-derived suppressor cells. J. Immunol. 182, 5693–5701
49. Holmstr o¨ m, K. M., and Finkel, T. (2014) Cellular mechanisms and physi-
2
3
9. Oba, M., Iida, M., and Nishiyama, K. (2001) Generation and reactions of
transient 9-silaphenanthrene derivative. Organometallics 20, 4287–4290
0. Cookson, E. A., and Crofts, P. C. (1966) Phosphorus heterocycles. Part I. A
MARCH 25, 2016•VOLUME 291•NUMBER 13
JOURNAL OF BIOLOGICAL CHEMISTRY 7043